200 1 is listed as a national key innovation project.
In 2002, he applied for a patent for the invention of enzymatic process.
In July 2005, he obtained the invention patent certificate.
June 2004: 5438+ 10, the first company to obtain the production approval number.
Comparison of Enzymatic Synthesis and Chemical Synthesis for the Production of Creatine Phosphate Sodium; Enzymatic Synthesis of Chemical Synthesis Raw Material: adenosine triphosphate (ATP)
Implementation standard: National Pharmacopoeia Standard 2005.
ATP is a high-energy compound, which is closely related to tissue growth, repair, regeneration and energy supply. Chemical raw materials: phosphorus oxychloride (dangerous goods)
Implementation standard: chemical industry standard. Phosphorus oxychloride is a smoky liquid with pungent smell. When placed in humid air, hydrolysis produces phosphoric acid and hydrogen chloride, resulting in white smoke. When it meets water and ethanol, it will decompose and release a lot of heat and hydrogen chloride. It is irritating to the eyes. Corrosive. It is a first-class acidic corrosive product with mild reaction conditions, safety and strong operability. The reaction conditions are easy to control, and the reaction products are specific and high in purity. The product has high purity and high environmental protection index. No harmful waste is produced in the production process, and its by-products can be used as the final product of chemical fertilizer.
Creatine phosphate sodium meets the legal quality standard (content above 98%), and the final product meets the legal quality standard (content above 99%).
The by-product of creatine phosphate sodium is ATPADP, and the by-products are creatinine and creatine phosphate anhydride, which simulates the synthesis process of creatine phosphate in human body, avoids the residue of harmful intermediates, and the specificity and controllability of enzymatic reaction ensure that the high-purity production process of the product is mild and easy to control.
The preparation of creatine kinase with independent intellectual property rights is the key technology of enzymatic synthesis with high conversion rate. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
20-year invention patent protection
PatentNo.: ZL 02 129203.5 _ _ _ _ _ _ _ Total battery protection
Membrane protection: stabilize cell membrane and mitochondrial membrane, maintain normal cell morphology and normal physiological function.
Microcirculation: improve red blood cell function, inhibit platelet aggregation, and effectively improve blood supply in ischemic areas.
Free radicals: reduce the production of free radicals and protect cells from free radicals.
Ion pump: improve the function of ion pump, promote K+ inflow and eliminate calcium overload.
Contraction protein: reduce injury and maintain normal contraction function.
The most direct energy supplier
Energy supply: the most direct source of energy supply directly penetrates the cell membrane to produce ATP.
Energy transport: ATP is transported from the production site (mitochondria) to the site requiring energy (ion pump, muscle fiber, etc.). )
Productivity: inhibit anaerobic glycolysis and prolong aerobic metabolism.
Energy conservation: inhibit adenosine degradation and maintain high-energy phosphorylation level in cells.